With a $42M raise and a re­verse merg­er, Syn­log­ic makes a quick flip on­to Nas­daq

Jose Car­los Gutier­rez-Ramos has found the back door to Nas­daq.

The CEO at Cam­bridge, MA-based Syn­log­ic is ex­e­cut­ing a re­verse merg­er with the failed Austin-based biotech Mir­na Ther­a­peu­tics, which will put the syn­thet­ic bi­ol­o­gy com­pa­ny in­to the pub­lic mar­ket. And in ad­di­tion, the  biotech says that it re­cent­ly closed a $42 mil­lion C round to back its tran­si­tion in­to the spot­light of pub­lic re­port­ing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.